Mason T. Breitzig, PhD

Henry Ford Health, Center for Healthcare Improvement, Detroit, Michigan; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, Pennsylvania

  • 2Articles
  • 11.7KReads
  • 2024–2026Active
  • 9Collaborators
  • 2Citations

About

Mason T. Breitzig, PhD, is affiliated with Henry Ford Health's Center for Healthcare Improvement in Detroit, Michigan, and the Department of Psychiatry and Behavioral Health at Penn State College of Medicine in Hershey, Pennsylvania. Breitzig has published research on the pharmacotherapy of major depressive disorder, focusing on guideline concordance and symptom severity, as well as the prevalence of GLP-1 receptor agonist use among individuals with mood disorders. Their work addresses clinical aspects of depression, mood disorders, and weight management. Breitzig's articles have appeared in Psychiatrist.com between 2024 and 2026.

Publications

JCP
Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders
JCP
Guideline Concordance in Major Depressive Disorder

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.